Niacin in Primary Prevention: Outcome Trials
Niacin in Primary Prevention: Outcome Trials: What the strongest studies and guidelines say, in plain language.
Key Takeaways
- Clear indication before use; avoid routine megadoses.
- Exact dosing and retest timing improve outcomes.
- Watch interactions and contraindications.
Details
We synthesize guideline and trial data into practical steps: when to use, how much, how long, and when to reassess. Always consider individual context, medications, and labs.
References (selected)
- Guidelines and meta-analyses summarized. Cite primary sources in clinical use.
Educational only; not medical advice.